Sheba Partners with Shortwave Pharma to test Psilocybin

In a first of its kind clinical trial, Sheba Medical Center will be partnering with Short Wave Pharma to study the safety and possibility of psilocybin-assisted psychotherapy for the treatment of anorexia nervosa. The study is currently preparing for participant recruitment.

“We are honored to partner with Dr. (Eitan) Gur, Mr. (Yoel) Golbert and the Sheba Center for Eating Disorders in this important study. Anorexia nervosa is a devastating and complex illness, shattering lives of patients, mostly women and girls, and their families. Psychedelics present a new paradigm in mental healthcare, with the potential to positively impact some facets of this disease,” said Rivki Stern, CEO of Short Wave.

Read more here.

Whether helping those most in need or advancing healthcare globally:
when you support Sheba, you are making a difference.